D-0990-2019 Class III Terminated
FDA drug recall D-0990-2019 was initiated by AVKARE Inc. on Mar 1, 2019 and is designated Class III. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Jan 14, 2020). Affected quantity: a) 2947 and b) 3379.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 20, 2019
- Initiation Date
- Mar 1, 2019
- Termination Date
- Jan 14, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- a) 2947 and b) 3379
Product description
Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 42291-634-01) and b) 500 tablets (NDC 42291-634-50) bottles, Rx Only Manufactured for: AvKARE, Inc. Pulaski, TN 38478
Reason for recall
Failed Dissolution Specifications
Distribution pattern
Nationwide.
Code information
Lots: a) 22738 Exp. 07/2020 and b) 22739 Exp. 07/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0990-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026